Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN113201006B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113201006B details a mild Rh-catalyzed C-H activation route for acylsilicon-substituted isoindol-1-one analogs, offering significant cost and efficiency advantages for pharmaceutical intermediate manufacturing.